Abstract:Understanding the disease pathogenesis of the novel coronavirus, denoted SARS-CoV-2, is critical to the development of anti-SARS-CoV-2 therapeutics. The global propagation of the viral disease, denoted COVID-19 ("coronavirus disease 2019"), has unified the scientific community in searching for possible inhibitory small molecules or polypeptides. Given the known interaction between the human ACE2 ("Angiotensin-converting enzyme 2") protein and the SARS-CoV virus (responsible for the coronavirus outbreak circa. … Show more
“…We highlight those 279 pairs within the predicted all interactome, the 129 pairs within the predicted proximal schema, and the 539 pairs within the predicted RP-PPI schema. All data are published in the following DataVerse repository, for broader use by the scientific community ( Dick, Biggar & Green, 2020 ).…”
Section: Resultsmentioning
confidence: 99%
“…For example, among the tables for the all schema, the Molecular Functions exhibiting a fold enrichment greater than 3 are reported; the Biological Processes exhibiting a fold enrichment greater than 50 are reported; and the Cellular Components exhibiting a fold enrichment greater than 15 are reported. The fold enrichment cut-offs were selected to limit the size of the tables; the complete tables are available in the appendix of the Supplemental Information and at at public repository, Dick, Biggar & Green (2020) .…”
Section: Resultsmentioning
confidence: 99%
“…In the present study, of the ∼285,000 host-virus pairs, we leverage three prediction schema and two independent PPI predictors to select a highly conservative set of predicted interactions for each of the 14 SARS-CoV-2 proteins considered in this study resulting in the identification of several putative human protein targets. We have publicly released these predictions and related meta-data for use by the broader scientific community in the following DataVerse repository: https://www.doi.org/10.5683/SP2/JZ77XA ( Dick, Biggar & Green, 2020 ).…”
Background
Understanding the disease pathogenesis of the novel coronavirus, denoted SARS-CoV-2, is critical to the development of anti-SARS-CoV-2 therapeutics. The global propagation of the viral disease, denoted COVID-19 (“coronavirus disease 2019”), has unified the scientific community in searching for possible inhibitory small molecules or polypeptides. A holistic understanding of the SARS-CoV-2 vs. human inter-species interactome promises to identify putative protein-protein interactions (PPI) that may be considered targets for the development of inhibitory therapeutics.
Methods
We leverage two state-of-the-art, sequence-based PPI predictors (PIPE4 & SPRINT) capable of generating the comprehensive SARS-CoV-2 vs. human interactome, comprising approximately 285,000 pairwise predictions. Three prediction schemas (all, proximal, RP-PPI) are leveraged to obtain our highest-confidence subset of PPIs and human proteins predicted to interact with each of the 14 SARS-CoV-2 proteins considered in this study. Notably, the use of the Reciprocal Perspective (RP) framework demonstrates improved predictive performance in multiple cross-validation experiments.
Results
The all schema identified 279 high-confidence putative interactions involving 225 human proteins, the proximal schema identified 129 high-confidence putative interactions involving 126 human proteins, and the RP-PPI schema identified 539 high-confidence putative interactions involving 494 human proteins. The intersection of the three sets of predictions comprise the seven highest-confidence PPIs. Notably, the Spike-ACE2 interaction was the highest ranked for both the PIPE4 and SPRINT predictors with the all and proximal schemas, corroborating existing evidence for this PPI. Several other predicted PPIs are biologically relevant within the context of the original SARS-CoV virus. Furthermore, the PIPE-Sites algorithm was used to identify the putative subsequence that might mediate each interaction and thereby inform the design of inhibitory polypeptides intended to disrupt the corresponding host-pathogen interactions.
Conclusion
We publicly released the comprehensive sets of PPI predictions and their corresponding PIPE-Sites landscapes in the following DataVerse repository: https://www.doi.org/10.5683/SP2/JZ77XA. The information provided represents theoretical modeling only and caution should be exercised in its use. It is intended as a resource for the scientific community at large in furthering our understanding of SARS-CoV-2.
“…We highlight those 279 pairs within the predicted all interactome, the 129 pairs within the predicted proximal schema, and the 539 pairs within the predicted RP-PPI schema. All data are published in the following DataVerse repository, for broader use by the scientific community ( Dick, Biggar & Green, 2020 ).…”
Section: Resultsmentioning
confidence: 99%
“…For example, among the tables for the all schema, the Molecular Functions exhibiting a fold enrichment greater than 3 are reported; the Biological Processes exhibiting a fold enrichment greater than 50 are reported; and the Cellular Components exhibiting a fold enrichment greater than 15 are reported. The fold enrichment cut-offs were selected to limit the size of the tables; the complete tables are available in the appendix of the Supplemental Information and at at public repository, Dick, Biggar & Green (2020) .…”
Section: Resultsmentioning
confidence: 99%
“…In the present study, of the ∼285,000 host-virus pairs, we leverage three prediction schema and two independent PPI predictors to select a highly conservative set of predicted interactions for each of the 14 SARS-CoV-2 proteins considered in this study resulting in the identification of several putative human protein targets. We have publicly released these predictions and related meta-data for use by the broader scientific community in the following DataVerse repository: https://www.doi.org/10.5683/SP2/JZ77XA ( Dick, Biggar & Green, 2020 ).…”
Background
Understanding the disease pathogenesis of the novel coronavirus, denoted SARS-CoV-2, is critical to the development of anti-SARS-CoV-2 therapeutics. The global propagation of the viral disease, denoted COVID-19 (“coronavirus disease 2019”), has unified the scientific community in searching for possible inhibitory small molecules or polypeptides. A holistic understanding of the SARS-CoV-2 vs. human inter-species interactome promises to identify putative protein-protein interactions (PPI) that may be considered targets for the development of inhibitory therapeutics.
Methods
We leverage two state-of-the-art, sequence-based PPI predictors (PIPE4 & SPRINT) capable of generating the comprehensive SARS-CoV-2 vs. human interactome, comprising approximately 285,000 pairwise predictions. Three prediction schemas (all, proximal, RP-PPI) are leveraged to obtain our highest-confidence subset of PPIs and human proteins predicted to interact with each of the 14 SARS-CoV-2 proteins considered in this study. Notably, the use of the Reciprocal Perspective (RP) framework demonstrates improved predictive performance in multiple cross-validation experiments.
Results
The all schema identified 279 high-confidence putative interactions involving 225 human proteins, the proximal schema identified 129 high-confidence putative interactions involving 126 human proteins, and the RP-PPI schema identified 539 high-confidence putative interactions involving 494 human proteins. The intersection of the three sets of predictions comprise the seven highest-confidence PPIs. Notably, the Spike-ACE2 interaction was the highest ranked for both the PIPE4 and SPRINT predictors with the all and proximal schemas, corroborating existing evidence for this PPI. Several other predicted PPIs are biologically relevant within the context of the original SARS-CoV virus. Furthermore, the PIPE-Sites algorithm was used to identify the putative subsequence that might mediate each interaction and thereby inform the design of inhibitory polypeptides intended to disrupt the corresponding host-pathogen interactions.
Conclusion
We publicly released the comprehensive sets of PPI predictions and their corresponding PIPE-Sites landscapes in the following DataVerse repository: https://www.doi.org/10.5683/SP2/JZ77XA. The information provided represents theoretical modeling only and caution should be exercised in its use. It is intended as a resource for the scientific community at large in furthering our understanding of SARS-CoV-2.
“…Besides using the experimental results of V-H PPIs, computationally predicted and curated PPIs are also being used for analyzing the pathogenesis of SARS-CoV-2 [ 33 ]. Several computational strategies, such as structure-, sequence- and evolution-based methods, have been conducted to analyze and quantify the intra-viral and V-H PPIs [ 31 , 32 , 34 ]. Structure-based methods for PPIs require the information on the 3D structure of both proteins.…”
Section: Various Interactions Help Delineating Sars-cov-2 Pathogenesimentioning
confidence: 99%
“…Dick et al . [ 32 ] have used two sequence-based PPI prediction approaches such as PIPE4 (Protein-Protein Interaction Prediction Engine) and SPRINT (Scoring PRotein INTeractions) to predict host protein interactions with 14 SARS-CoV-2 proteins and identified 279 putative interactions connecting with 225 human proteins. To train the predictors and infer new putative V-H interactions, experimentally elucidated human-virus PPIs of several viral organisms were used those obtained from the VirusMentha database ( https://virusmentha.uniroma2.it/ ).…”
Section: Various Interactions Help Delineating Sars-cov-2 Pathogenesimentioning
The coronavirus disease 2019 (COVID-19) pandemic, caused by the coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has created an unprecedented threat to public health. The pandemic has been sweeping the globe, impacting more than 200 countries, with more outbreaks still lurking on the horizon. At the time of the writing, no approved drugs or vaccines are available to treat COVID-19 patients, prompting an urgent need to decipher mechanisms underlying the pathogenesis and develop curative treatments. To fight COVID-19, researchers around the world have provided specific tools and molecular information for SARS-CoV-2. These pieces of information can be integrated to aid computational investigations and facilitate clinical research. This paper reviews current knowledge, the current status of drug development and various resources for key steps toward effective treatment of COVID-19, including the phylogenetic characteristics, genomic conservation and interaction data. The final goal of this paper is to provide information that may be utilized in bioinformatics approaches and aid target prioritization and drug repurposing. Several SARS-CoV-2-related tools/databases were reviewed, and a web-portal named OverCOVID (http://bis.zju.edu.cn/overcovid/) is constructed to provide a detailed interpretation of SARS-CoV-2 basics and share a collection of resources that may contribute to therapeutic advances. These information could improve researchers’ understanding of SARS-CoV-2 and help to accelerate the development of new antiviral treatments.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.